ISSUE #16 Dec 10, 2025
We are pleased to announce that the 5th East-West Biopharma Summit,
co-hosted by BioCentury Inc., Maeil Business Newspaper, and KoreaBIO,
will be held in Seoul for the first time, from March 9-11, 2026.

This premier event offers multiple ways to participate:
registration, IR presentation applications, and sponsorship opportunities!

On November 28, 2025, the 2025 Bio Industry Day, hosted by the Ministry of Trade, Industry and Energy and organized by KoreaBIO, honored 45 contributors to Korea's bio industry.
About 200 participants from government and industry attended to celebrate achievements and encourage further sector growth.
On December 4, 2025, KoreaBIO held a forum to discuss industry trends and policy directions as AI rapidly expands across biomanufacturing, R&D, food, and advanced materials.
Around 150 industry professionals participated in sharing insights on the evolving AI-driven bio ecosystem.
∎ Celltrion launches Remsima SC in Chile, marking first entry into Latin American public markets - THE BIO
∎ Eli Lilly, SK Launch First Domestic GLP-1 Obesity Drug Production - THE CHOSUN Daily
∎ GC Biopharma Ships First Doses of World’s First Recombinant Anthrax Vaccine, ‘BARYTHRAX inj.’ - BioSpace
∎ Hanmi Pharm’s Next-Generation Anticancer Drug Trials Advance Globally - Business Korea
∎ Samsung Bioepis brings 10 biosimilar products to European market - Pulse
∎ ToolGen prevails in the European CRISPR RNP plant patent case, marking an unprecedented reversal of the preliminary ruling - THE BIO
∎ Cha Bio signs US healthcare MOU with Hanwha Life and Hanwha General Insurance - Chosun Biz
∎ Neurophet pushes Alzheimer’s imaging AI into Southeast Asia with new AQUA data - KBR
∎ Noul lands ₩1.1 bil. won AI cervical cancer diagnostic supply deal in Panama - KBR
∎ Lunit to Supply AI Foundation Model to 175 Medical Facilities in the US - The Asia Business Daily
∎ Pharma and bio firms embrace co-CEO model, refocus on new modalities - Pulse
∎ The Second Act of Korea's ADC War: The Battle Hinges on Overcoming Resistance - The Asia Business Daily
∎ Samsung Biologics to invest 7 trln won in third bio-campus - Aju Press
∎ SyntekaBio, Panolos Sign MOU on Next-Gen Multispecific Antibodies - Pharm E Daily
∎ Korea's SK Biopharmaceuticals expands radiopharmaceutical therapy portfolio - Biospectrum Asia
∎ CJ CheilJedang commercializes biodegradable PHA across Korea and global markets - Chosun Biz
∎ Chungnam launches Naepo agri-bio cluster to drive Korea bio and smart farming growth - Chosun Biz
∎ Chong Kun Dang, Asleep team up to market AI sleep apnea screening device Apnotrack - KBR
∎ DGIST Develops AI Foundation Model to Address Brain Signal Labeling Shortage - Asia Research News
📰
Join our press list
Get KoreaBIO updates
& media resources
💬
Share Your thoughts!
How was your letter today?
✉️
Korean Newsletter
Daily biotech news from Korea and around the world
— in Korean
Explore More
KoreaBIO (Korea Biotechnology Industry Organization)
700 Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea
+82-31-628-0037
수신거부 Unsubscribe